TTF-1 Expression in Pulmonary Adenocarcinomas

Tissue-specific gene expression is mediated largely by transcription factors, and a master regulatory gene is thus a potential marker of cellular lineage. Using normal fetal through adult pulmonary tissues and 64 consecutive lung adenocarcinomas, we examined the expression of thyroid transcription factor (TTF-1), which plays a crucial role in normal lung function and morphogenesis. TTF-1 was expressed consistently throughout the life stages and uniformly in the terminal respiratory unit, which is comprised of peripheral airway cells and small-sized bronchioles. Furthermore, the expression was maintained in 72% of adenocarcinomas that exhibited high correlation with surfactant apoprotein (p <0.001) and morphologic resemblance to terminal respiratory unit cells (p <0.001). The staining pattern was also uniform in the adenocarcinomas despite histologic and microenvironmental diversity in individual tumors and their metastatic foci. This consistency and uniformity, therefore, suggested that TTF-1 expression could be used as a lineage marker of terminal respiratory unit. We also identified interesting distinctions between TTF-1-positive and -negative adenocarcinomas based on their clinicopathologic features and expression of various cancer-associated genes. TTF-1-positive adenocarcinomas had statistically significant prevalence of female (p <0.01), nonsmoker (p <0.05), negative p53 staining (p <0.01), less frequent RB loss (p <0.05), and preserved expression of p27 (p <0.01). The results supported the TTF-1 lineage marker and suggested that molecular pathogenesis may in part be characterized by cellular lineage.

[1]  E. Lander,et al.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. di Loreto,et al.  TTF-1 gene expression in human lung tumours. , 1996, European journal of cancer.

[3]  P. Chu,et al.  Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases , 2000, Modern Pathology.

[4]  L. Lim,et al.  Thyroid transcription factor-1, hepatocyte nuclear factor-3beta, surfactant protein B, C, and Clara cell secretory protein in developing mouse lung. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[5]  E. Schaafsma,et al.  Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. , 1990, The American journal of pathology.

[6]  Dietel,et al.  Thyroid transcription factor‐1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B , 2000, Histopathology.

[7]  Robert K. Davis,et al.  The myoD gene family: nodal point during specification of the muscle cell lineage. , 1991, Science.

[8]  Rochelle L. Garcia,et al.  Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[9]  Y. Yatabe,et al.  Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. , 1998, Cancer research.

[10]  R. Lloyd,et al.  Thyroid Transcription Factor-1 Distinguishes Metastatic Pulmonary From Well-Differentiated Neuroendocrine Tumors of Other Sites , 2001, The American journal of surgical pathology.

[11]  Y. Shimosato [Histological Typing of Lung and Pleural Tumors (3rd edition, 1999): Malignant epithelial tumors]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[12]  G. Pelosi,et al.  Immunoreactivity for Thyroid Transcription Factor-1 in Stage I Non–Small Cell Carcinomas of the Lung , 2001, The American journal of surgical pathology.

[13]  C. I. Smith,et al.  Correlation of expression of transcription factor C/EBP alpha and surfactant protein genes in lung cells. , 1995, The American journal of physiology.

[14]  Y. Yatabe,et al.  Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  Y. Yatabe,et al.  p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas. , 1998, Cancer research.

[16]  J. Whitsett,et al.  Lung Cell-specific Expression of the Murine Surfactant Protein A (SP-A) Gene Is Mediated by Interactions between the SP-A Promoter and Thyroid Transcription Factor-1 (*) , 1995, The Journal of Biological Chemistry.

[17]  J. Whitsett,et al.  Expression of thyroid transcription factor-1(TTF-1) in fetal and neonatal human lung. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[18]  Xin Li,et al.  Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas. , 2000, Human pathology.

[19]  D. Botstein,et al.  Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  C. Bingle,et al.  The lung enriched transcription factor TTF-1 and the ubiquitously expressed proteins Sp1 and Sp3 interact with elements located in the minimal promoter of the rat Clara cell secretory protein gene. , 1996, The Biochemical journal.

[21]  J. Whitsett,et al.  Transcriptional Control in the Developing Lung , 1997 .

[22]  R. Lauro,et al.  The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis , 1994, Molecular and cellular biology.

[23]  F. Puglisi,et al.  Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[24]  W. Travis,et al.  Alveolar adenoma: a histochemical, immunohistochemical, and ultrastructural analysis of 17 cases. , 1999, Human pathology.

[25]  Y. Nikiforov,et al.  Thyroid Transcription Factor-1, Thyroglobulin, Cytokeratin 7, and Cytokeratin 20 in Thyroid Neoplasms , 2000, Applied immunohistochemistry & molecular morphology : AIMM.

[26]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[27]  F. Puglisi,et al.  Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma. , 1997, Journal of clinical pathology.

[28]  J. Rosai,et al.  Cytokeratin-positive malignant tumors with reticulum cell morphology: a subtype of fibroblastic reticulum cell neoplasm? , 2000, The American journal of surgical pathology.

[29]  B. Westermark,et al.  The molecular biology of the human anaplastic thyroid carcinoma cell. , 1991, Thyroidology.

[30]  J. Whitsett,et al.  Upstream Enhancer Activity in the Human Surfactant Protein B Gene Is Mediated by Thyroid Transcription Factor 1 (*) , 1995, The Journal of Biological Chemistry.

[31]  S. E. Kelly,et al.  Transcription of the Lung-specific Surfactant Protein C Gene Is Mediated by Thyroid Transcription Factor 1 (*) , 1996, The Journal of Biological Chemistry.

[32]  Y. Yatabe,et al.  Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  P. Minoo,et al.  Defects in tracheoesophageal and lung morphogenesis in Nkx2.1(-/-) mouse embryos. , 1999, Developmental biology.

[34]  N. Ordóñez Value of Thyroid Transcription Factor-1 Immunostaining in Distinguishing Small Cell Lung Carcinomas From Other Small Cell Carcinomas , 2000, The American journal of surgical pathology.

[35]  R. Ueda,et al.  Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  C. Mendelson,et al.  Role of transcription factors in fetal lung development and surfactant protein gene expression. , 2000, Annual review of physiology.

[37]  J. Minna,et al.  Molecular genetics of small cell lung carcinoma. , 2001, Seminars in oncology.

[38]  Dietel,et al.  Expression of thyroid transcription factor‐1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites , 2000, Histopathology.

[39]  V. Venkatesh,et al.  Characterization of the promoter of human pulmonary surfactant protein B gene. , 1995, The American journal of physiology.

[40]  N. Ordóñez,et al.  Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. , 2000, Advances in anatomic pathology.

[41]  R. Katoh,et al.  Thyroid Transcription Factor-1 in Normal, Hyperplastic, and Neoplastic Follicular Thyroid Cells Examined by Immunohistochemistry and Nonradioactive In Situ Hybridization , 2000, Modern Pathology.

[42]  W. Travis,et al.  A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. , 2000, The American journal of surgical pathology.

[43]  M. Miettinen,et al.  Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[44]  J. Whitsett,et al.  Transcriptional control in the developing lung. The Parker B. Francis lectureship. , 1997, Chest.

[45]  R. Lauro,et al.  The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. , 1991, Development.

[46]  C H Fox,et al.  The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. , 1996, Genes & development.

[47]  S. Feinstein,et al.  Transcriptional activation and protein binding by two regions of the rat surfactant protein A promoter. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[48]  J. Chan,et al.  Pulmonary Sclerosing Hemangioma Consistently Expresses Thyroid Transcription Factor-1 (TTF-1): A New Clue to Its Histogenesis , 2000, The American journal of surgical pathology.

[49]  J. Minna,et al.  The biology of non-small cell lung cancer. , 1983, Seminars in oncology.